Collectively, these results suggest that β4 integrin enables the physical recruitment and subsequent activation of FAK, which promotes AKT and p38MAPK signaling in an EGF/Src dependent manner, thereby regulating breast cancer malignancy. The gene discussed is PTK2; the disease is breast cancer.